Alternative Asset Manager Brookfield’s Diversification, Exploring UK Pension Insurance with Possible Acquisitions

Brookfield Corporation (NYSE: BN) and its affiliate Brookfield Reinsurance Ltd (NYSE: BNRE) are reportedly exploring the possibility of venturing into the U.K.’s pension insurance sector.  This exploration focuses on the bulk annuities segment, where potential acquisition targets may include companies like Just Group and Pension  Bulk annuities represent a type of insurance that enables companies’ pension plans to transfer their liabilities […]

Why Is Alzheimer’s Player Prothena Stock Trading Higher Today?

Prothena Corporation plc (NASDAQ: PRTA) is reportedly talking to advisors, potentially preparing for a sale. The closely watched Alzheimer’s player is due to report key data expected in the coming months. Prothena’s wholly owned programs include birtamimab for AL amyloidosis and a portfolio of programs for the potential treatment of Alzheimer’s disease, including PRX012 that targets Aβ (amyloid beta) […]

Shutdown Averted, Treasury Yields Flirt With 5%, Strong Payrolls Add to Fed Tightening Risk: The Week In The Markets

A week filled with significant events impacting the markets culminated in an unexpectedly strong September jobs report. Government Shutdown Averted; House Ousts McCarthy: The U.S. Congress managed to avoid a dramatic government shutdown just hours before the midnight deadline Oct. 1 by passing a stopgap funding bill. This bill ensures the continuation of government operations […]

Amgen’s Adcomm Meeting Paves Way To Launch Boost For Mirati Therapeutics’ Lung Cancer Drug: Analysts

According to a report on Thursday, French pharma company Sanofi SA (NASDAQ: SNY) is reportedly exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc (NASDAQ: MRTX). The deal would potentially bolster Sanofi’s drug pipeline, helping the company to reduce its reliance on the blockbuster asthma medicine Dupixent.  Sanofi’s backing would also help Mirati commercialize Krazati and fund treatment and further […]

Is Cupertino’s Next Trick A USB-C-Powered Apple Pencil 3? iOS 17.1 Beta 2 Drops Clues

The discovery of a code reference within Apple Inc.’s (NASDAQ:AAPL) latest operating version, iOS 17.1 Beta 2, has raised questions about the potential development of an Apple Pencil 3 featuring USB-C charging support. What Happened: The 10.9-inch iPad, released in October last year, had posed a challenge regarding Apple Pencil compatibility. Due to design constraints, it couldn’t support the magnetic second-generation Apple Pencil, […]

Novartis Mulls Divesting Some Assets Of Radiopharma Unit In Strategic Shift

Swiss pharmaceutical giant Novartis AG (NYSE: NVS) is reportedly contemplating selling sections of radiopharmaceuticals company Advanced Accelerator Applications to align with the company’s strategy and the broader industry trend to shed low-growth segments. Novartis is currently in the initial phase of assessing a potential sale. Although discussions are underway, there remains uncertainty surrounding the outcome, emphasizing that a deal […]

Analyzing Long-Term Negative Responses To Psychedelics: Researchers Release Study

The journal Nature published a new research analysis from Imperial College London (ICL)’s Center for Psychedelic Research and University of California San Francisco (UCSF)’s Psychedelics Division, including renowned David Erritzoe and Robin Carhart-Harris. The study looks at cases where there have been long-term negative psychological responses to psychedelics.  The study was motivated by an alleged ongoing research and reporting bias on […]